CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, announced today organizational changes to the executive leadership team to position the ...

Efforts will focus on the development of FoundationOne ® CDx as a companion diagnostic for Day One’s tovorafenib, which is in late-stage clinical development for pediatric low-grade glioma CAMBRIDGE, ...

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced it will showcase data across its portfolio of high-quality comprehensive genomic profiling tests at the ...

Foundation Medicine, Inc., a global, patient-focused precision medicine company , today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne ® CDx ...

Pharmaceutical giant Roche Holding will pay $2.4 billion to acquire the remaining shares it doesn’t already own of Foundation Medicine, putting more stake into a future for personalized cancer ...

Fifth Partnership Will Help Translate Cancer Genomic Science to Clinical Results CAMBRIDGE, Mass.--(BUSINESS WIRE)--Foundation Medicine, Inc., a molecular information company that brings comprehensive ...

Whole Genome Sequencing (WGS) test now available through Foundation Medicine’s FlexOMx Lab™ to support biomarker discovery and drug development across cardiometabolic, immunologic and neurologic ...

LYNPARZA was approved based on positive results from the PROfound study for which Foundation Medicine served as the Next-Generation Sequencing (NGS) partner Prostate cancer is the second most common ...

Foundation Medicine announced a partnership with Epic Thursday, meant to integrate its services like comprehensive genomic profiling with the electronic medical record (EMR) system. Providers will be ...

Foundation Medicine and Epic struck a deal to integrate comprehensive genomic profiling within Epic's electronic health records (EHRs), allowing for providers to order and review genomic profiling ...

"As biopharmaceutical pipelines expand targeted therapies beyond the traditional oncology space and into different areas of medicine, the demand for quality germline data has never been greater," said ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genome analysis to routine clinical care, today announced the initiation ...